Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

A patient lost all their hair while on rheumatoid arthritis medication.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

Two new signs, 'signet ring vessels' and 'hidden hairs,' help tell apart scalp psoriasis and seborrheic dermatitis.

About 11% of patients with secondary syphilis had Syphilitic Alopecia, which usually improved with treatment.

LC-OCT is an effective new method for diagnosing classic lichen planopilaris.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Substance P may play a role in the inflammation seen in keratosis follicularis spinulosa decalvans.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

A young man was initially misdiagnosed with a scalp condition but was found to have a fungal infection, which improved with antifungal treatment.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.